BIO-GENE TECHNOLOGY LTD

3.03%

3.4¢

Market Cap $9.151M

Healthcare Biotechnology

Bio-Gene Technology Limited is an Australia-based agriculture technology development... Bio-Gene Technology Limited is an Australia-based agriculture technology development company enabling the next generation of novel bio-insecticides. Its products are based on a naturally occurring class of compounds proven to overcome resistance to control pests with minimal impact on human health and the environment. Its products have multiple applications across crop protection, grain storage, public health and consumer uses. Flavocide and Qcide are the Company’s lead beta-triketone insecticide products. Flavocide is a natural beta-triketone molecule produced synthetically by a chemical process. Qcide is a natural oil product containing tasmanone as the active constituent. The oil is extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana), by utilizing a steam distillation process. The Company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.More

Latest Threads

Tag

Subject

BGT

Ann: Flavocide Reproductive Toxicity Study Underway

16:47

307

16:47

Last post stormer

307

BGT

Ann: CFO and Company Secretary Appointment/Resignation

02/02/26

314

02/02/26

Last post stormer

314

BGT

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

01/02/26

268

01/02/26

Last post beaches811

268

BGT

Media

22/01/26

742

22/01/26

Last post Sharkbait07

742

BGT

Ann: Outcome of review of Continuous Disclosure Procedures

15/01/26

1.6K

15/01/26

Last post masters

1.6K

BGT

Ann: U.S. Department of Defense Grant Programs Advance

31/12/25

1.3K

31/12/25

Last post beaches811

1.3K

BGT

Ann: Bio-Gene Receives $519,500 R&D Tax Incentive

26/11/25

735

26/11/25

Last post beaches811

735

BGT

Ann: CEO's Presentation

23/11/25

589

23/11/25

Last post stormer

589

See All Discussions

Timeline

Flavocide Reproductive Toxicity Study Underway
09 Feb 09:31	Share

CFO and Company Secretary Appointment/Resignation
02 Feb 09:11	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 08:24	Share

U.S. Department of Defense Grant Programs Advance
18 Dec 08:53	Share

Outcome of review of Continuous Disclosure Procedures
02 Dec 08:21	Share

Bio-Gene Receives $519,500 R&D Tax Incentive
25 Nov 08:16	Share

Results of Meeting
19 Nov 15:42	Share

CEO's Presentation
19 Nov 14:20	Share

Chair's Address to Shareholders
19 Nov 14:18	Share

Qcide receives organic listing status in USA
14 Nov 08:19	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Oct 08:17	Share

Review of Continuous Disclosure Procedures
23 Oct 13:44	Share

Notice of Annual General Meeting/Proxy Form
17 Oct 16:54	Share

Date of 2025 Annual General Meeting
30 Sep 12:44	Share

Response to ASX Aware Letter
29 Sep 13:41	Share

Positive Flavocide Efficacy Results Presented
23 Sep 09:29	Share

Corporate Governance Statement
26 Aug 09:49	Share

Appendix 4G
26 Aug 09:08	Share

Appendix 4E and 2025 Annual Report
26 Aug 08:45	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 08:11	Share

Change in substantial holding
24 Jul 15:35	Share

Change in substantial holding
24 Jul 15:33	Share

Change in substantial holding
23 Jul 12:28	Share

Placement completed and Cleansing Notice
21 Jul 10:53	Share

Change of Director's Interest Notice AG
21 Jul 09:22	Share

Change of Director's Interest Notice AD
21 Jul 09:21	Share

Change of Director's Interest Notice PM
21 Jul 09:19	Share

Change of Director's Interest Notice TG
21 Jul 09:17	Share

Notification regarding unquoted securities - BGT
21 Jul 08:52	Share

Notification regarding unquoted securities - BGT
21 Jul 08:50	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.4¢		Change 0.001(3.03%)		Mkt cap ! $9.151M

Open	High	Low	Volume
3.3¢	3.4¢	3.3¢	15.15K

Buyers (Bids)

Vol.	Price($)
32769	3.1¢

Sellers (Offers)

Price($)	Vol.
3.4¢	86734

Last trade - 15.04pm 09/02/2026 (20 minute delay)

BGT (ASX) Chart

BIO-GENE TECHNOLOGY LTD

Latest Threads

PSC Delivers 63% Resource Growth at Mumbezhi, Copper Nears 800KT

Timeline

Featured News

Latest Videos

Bio-Gene Technology (ASX: BGT) notches another US patent

02 Aug 2023 15:29 (AEST)

Bio-Gene Technology (ASX:BGT) lands new US patent approval for Flavocide insect control

17 Mar 2023 11:45 (AEDT)

Bio-Gene Technology (ASX:BGT) receives $446k R&D tax incentive

20 Jan 2023 10:38 (AEDT)

Latest Articles

Bio-Gene jumps 60% on liquidity spike after positive data shown at international tick-borne disease conference

Bio-Gene Technology has jumped on Tuesday after confirming the potential for use of its flagship product in hospitals and on farms.

Bio-Gene jumps sharply as US DoD awards grants for novel insecticide development

Bio-Gene Technology (ASX:BGT) has revealed its receipt of contracts from the US Department of Defence to assess BGT's insecticides.

Bio-Gene Technology (ASX:BGT) enters global collaboration with STK

Agtech development company Bio-Gene Technology (BGT) has agreed to enter a global collaboration with STK Bio-Ag Technologies, an Israel-based Agtech company most known for its botanical-based solutions for crop protection.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News